Annual report pursuant to Section 13 and 15(d)

Fair Value of Financial Instruments (Details Textual)

v3.6.0.2
Fair Value of Financial Instruments (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Jan. 02, 2016
Dec. 27, 2014
Fair Value of Financial Instruments (Textual) [Abstract]      
Realized gain (loss) on available for sale securities $ (395,000) $ (1,102,000)  
Impairment charges 276,000 875,000  
Recognized expense related to deferred director stock units and phantom stock units liability 10,000 17,000 $ 35,000
Nonrecurring [Member]      
Fair Value of Financial Instruments (Textual) [Abstract]      
Fair value adjustments for assets measured at fair value 0    
Fair value adjustments for liabilities measured at fair value 0    
Deferred director stock units and phantom stock units liability [Member]      
Fair Value of Financial Instruments (Textual) [Abstract]      
Recognized expense related to deferred director stock units and phantom stock units liability $ 10,000 $ 17,000  
Phantom Share Units (PSUs) [Member]      
Fair Value of Financial Instruments (Textual) [Abstract]      
Vesting period 3 years